THE NAKI THERAPEUTICS

NAKI Therapeutics is an innovative research-focused biopharmaceutical company. Our core technology is surrounding Chimeric Antigen Receptor (CAR)-Natural Killer (NK) immunotherapy with ground-breaking allogeneic or ‘off-the-shelf' expansion technology and a ‘first-in-class' solid tumor molecular target-CD147... NAKI Therapeutics has developed a novel technology to expand "memory-like" CAR-NK cells by enriching CAR-NK metabolic pathways, which significantly enhances the persistence of CAR-NK cells in vivo.

Also known as: NAKI Therapeutics, The NAKI Therapeutics Inc.

Primary location: United States